Gomes, ARAbrantes, AMBrito, AFLaranjo, MCasalta-Lopes, JEGonçalves, ACSarmento-Ribeiro, ABBotelho, MFTralhão, JG2016-05-112016-05-112015-09Clin Mol Hepatol. 2015 Sep;21(3):257-67.http://hdl.handle.net/10400.4/1898Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide, and it has a poor prognosis and few therapeutic options. Radiotherapy is one of the most effective forms of cancer treatment, and P53 protein is one of the key molecules determining how a cell responds to radiotherapy. The aim of this study was to determine the therapeutic efficacy of iodine-131 in three human HCC cell lines.engCarcinoma HepatocelularProteína Supressora de Tumor p53journal article10.3350/cmh.2015.21.3.257